A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
Conditions
Relapsed/Refractory Multiple Myeloma (RRMM)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Aalborg Sygehus Syd, Aalborg, Denmark
Aarhus Universitetshospital, Aarhus N, Denmark
Rigshospitalet, Copenhagen, Denmark
Odense University Hospital, Odense, Denmark
Sygehus Lillebælt, Vejle, Vejle, Denmark
Hopital Albert Calmette - CHU Lille, Lille, France
Institut Paoli Calmettes, Marseille, France
CHU de Nantes hotel Dieu, Nantes, France
Hopital Saint Louis, Paris, France
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
CHRU de Nancy - Hopitaux de Brabois, Vandœuvre-lès-Nancy, France
Klinikum Chemnitz gGmbH, Chemnitz, Germany
Universitatsklinikum Carl Gustav Carus Dresden, Dresden, Germany
University Hospital Hamburg Eppendorf, Hamburg, Germany
Klinikum Region Hannover Klinikum Siloah, Hanover, Germany
Uniklinikum Heidelberg 1, Heidelberg, Germany
Klinikum Nurnberg Nord, Nuremberg, Germany
Universitätsklinikum Würzburg Med. Klinik U. Poliklinik Ii, Würzburg, Germany
University Hospital of Alexandroupolis, Alexandroupoli, Greece
Laiko General Hospital of Athens, Athens, Greece
Alexandra Hospital, Athens, Greece
University Hospital of Crete, PAGNI, Heraklion, Greece
Ioannina University Hospital, Ioannina, Greece
University Hospital Of Larissa, Larissa, Greece
Anticancer Hospital of Thessaloniki Theageneio, Thessaloniki, Greece
Ahepa University General Hospital of Thessaloniki, Thessaloniki, Greece
G Papanikolaou Hospital of Thessaloniki, Thessaloniki, Greece
Cork University Hospital, Cork, Ireland
Bon Secours Hospital, Cork, Ireland
St James Hospital, Dublin, Ireland
Beacon Hospital, Dublin, Ireland
University Hospital Galway - Ireland, Galway, Ireland
Hadassah Medical Center, Jerusalem, Israel
Sheba Medical Center, Ramat Gan, Israel
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Policlinico Sant'Orsola Malpighi, Bologna, Italy
Azienda Sanitaria dell'Alto Adige - Ospedale di Bolzano, Bolzano, Italy
Ospedale A.Perrino di Brindisi, Brindisi, Italy
AOU Careggi, Florence, Italy
Ospedale Vito Fazzi, Lecce, Italy
Policlinico di Milano, Milan, Italy
IRCCS Istituto Europeo di Oncologia, Milan, Italy
Azienda Ospedaliera Universitaria Federico II, Naples, Italy
Casa di Cura La Maddalena, Palermo, Italy
Universita Cattolica del Sacro Cuore - Fondazione Policlinico Universitario 'A. Gemelli', Roma, Italy
Presidio Ospedaliero Santo Spirito in Sassia, Roma, Italy
Ospedale Andrea Tortora Pagani Salerno, Salerno, Italy
Ospedale Ca' Foncello, Treviso, Italy
Azienda Sanitaria Universitaria Giuliano Isontina Ospedale Maggiore, Trieste, Italy
Ospedale Castelli, Verbania, Italy
Ospedale San Bortolo, Vicenza, Italy
Akershus Universitetssykehus, Oslo, Norway
Vestfold Hospital Trust, Tønsberg, Norway
Hosp. Ntra. Sra. de Sonsoles, Ávila, Spain
Hosp. Univ. Virgen de Las Nieves, Granada, Spain
Hosp. Univ. de La Princesa, Madrid, Spain
Hosp. Univ. de La Paz, Madrid, Spain
Hosp. Costa Del Sol, Málaga, Spain
Hosp. Clinico Univ. de Valencia, Valencia, Spain
Hosp. Alvaro Cunqueiro, Vigo, Spain
Sahlgrenska University Hospital, Gothenburg, Sweden
Länssjukhuset Ryhov, Jönköping, Sweden
Karolinska Universitetssjukhuset, Stockholms, Sweden
Uddevalla Hospital, Uddevalla, Sweden
Queen Elizabeth Hospital, Birmingham, United Kingdom
University College Hospital, London, United Kingdom
Guys and St Thomas NHS Foundation Trust, London, United Kingdom
The Royal Wolverhampton Hospitals NHS Trust - New Cross Hosp, Wolverhampton, United Kingdom
Study leads
Janssen-Cilag Limited Clinical Trial
Study Director
Janssen-Cilag Limited